Injectable intraocular corticosteroids

Research output: Chapter in Book/Report/Conference proceedingChapter

3 Citations (Scopus)

Abstract

Although risks are present, intravitreal corticosteroid injection is a relatively safe and effective treatment in a variety of conditions. Risks of intravitreal steroid injection include, but are not limited to, elevation of intraocular pressure, infection, cataract, retinal detachment, and central retinal artery occlusion. Although most observations regarding intravitreal corticosteroid injection derive from treating diabetic macular edema and age-related macular degeneration, this approach is beneficial in a number of uveitic conditions.

Original languageEnglish (US)
Title of host publicationSurgical Management of Inflammatory Eye Disease
PublisherSpringer Berlin Heidelberg
Pages5-16
Number of pages12
ISBN (Print)9783540338611
DOIs
StatePublished - 2008

Fingerprint

Intravitreal Injections
Adrenal Cortex Hormones
Injections
Retinal Artery Occlusion
Macular Edema
Macular Degeneration
Retinal Detachment
Intraocular Pressure
Cataract
Steroids
Infection
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Kurz, P. A., Suhler, E., Flaxel, C., & Rosenbaum, J. J. (2008). Injectable intraocular corticosteroids. In Surgical Management of Inflammatory Eye Disease (pp. 5-16). Springer Berlin Heidelberg. https://doi.org/10.1007/978-3-540-33862-8_1

Injectable intraocular corticosteroids. / Kurz, Paul A.; Suhler, Eric; Flaxel, Christina; Rosenbaum, James (Jim).

Surgical Management of Inflammatory Eye Disease. Springer Berlin Heidelberg, 2008. p. 5-16.

Research output: Chapter in Book/Report/Conference proceedingChapter

Kurz, PA, Suhler, E, Flaxel, C & Rosenbaum, JJ 2008, Injectable intraocular corticosteroids. in Surgical Management of Inflammatory Eye Disease. Springer Berlin Heidelberg, pp. 5-16. https://doi.org/10.1007/978-3-540-33862-8_1
Kurz PA, Suhler E, Flaxel C, Rosenbaum JJ. Injectable intraocular corticosteroids. In Surgical Management of Inflammatory Eye Disease. Springer Berlin Heidelberg. 2008. p. 5-16 https://doi.org/10.1007/978-3-540-33862-8_1
Kurz, Paul A. ; Suhler, Eric ; Flaxel, Christina ; Rosenbaum, James (Jim). / Injectable intraocular corticosteroids. Surgical Management of Inflammatory Eye Disease. Springer Berlin Heidelberg, 2008. pp. 5-16
@inbook{161071ebca654723a52122128ad61cbb,
title = "Injectable intraocular corticosteroids",
abstract = "Although risks are present, intravitreal corticosteroid injection is a relatively safe and effective treatment in a variety of conditions. Risks of intravitreal steroid injection include, but are not limited to, elevation of intraocular pressure, infection, cataract, retinal detachment, and central retinal artery occlusion. Although most observations regarding intravitreal corticosteroid injection derive from treating diabetic macular edema and age-related macular degeneration, this approach is beneficial in a number of uveitic conditions.",
author = "Kurz, {Paul A.} and Eric Suhler and Christina Flaxel and Rosenbaum, {James (Jim)}",
year = "2008",
doi = "10.1007/978-3-540-33862-8_1",
language = "English (US)",
isbn = "9783540338611",
pages = "5--16",
booktitle = "Surgical Management of Inflammatory Eye Disease",
publisher = "Springer Berlin Heidelberg",

}

TY - CHAP

T1 - Injectable intraocular corticosteroids

AU - Kurz, Paul A.

AU - Suhler, Eric

AU - Flaxel, Christina

AU - Rosenbaum, James (Jim)

PY - 2008

Y1 - 2008

N2 - Although risks are present, intravitreal corticosteroid injection is a relatively safe and effective treatment in a variety of conditions. Risks of intravitreal steroid injection include, but are not limited to, elevation of intraocular pressure, infection, cataract, retinal detachment, and central retinal artery occlusion. Although most observations regarding intravitreal corticosteroid injection derive from treating diabetic macular edema and age-related macular degeneration, this approach is beneficial in a number of uveitic conditions.

AB - Although risks are present, intravitreal corticosteroid injection is a relatively safe and effective treatment in a variety of conditions. Risks of intravitreal steroid injection include, but are not limited to, elevation of intraocular pressure, infection, cataract, retinal detachment, and central retinal artery occlusion. Although most observations regarding intravitreal corticosteroid injection derive from treating diabetic macular edema and age-related macular degeneration, this approach is beneficial in a number of uveitic conditions.

UR - http://www.scopus.com/inward/record.url?scp=84891977376&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84891977376&partnerID=8YFLogxK

U2 - 10.1007/978-3-540-33862-8_1

DO - 10.1007/978-3-540-33862-8_1

M3 - Chapter

AN - SCOPUS:84891977376

SN - 9783540338611

SP - 5

EP - 16

BT - Surgical Management of Inflammatory Eye Disease

PB - Springer Berlin Heidelberg

ER -